Tricuspid regurgitation thresholds reassessed - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Tricuspid regurgitation thresholds reassessed

  • By

  • Kathryn Wighton

  • September 9, 2026

  • 4 min

Share

Clinical Scorecard: Tricuspid regurgitation thresholds reassessed

At a Glance

CategoryDetail
ConditionTricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy
Key MechanismsEchocardiographic thresholds for tricuspid regurgitation provide prognostic discrimination.
Target PopulationAdult patients with newly diagnosed transthyretin amyloid cardiomyopathy.
Care SettingHigh-volume tertiary referral centers.

Key Highlights

  • Study involved 1,124 patients across multiple European countries.
  • Proposed thresholds for tricuspid regurgitation are lower than current guidelines.
  • Significant mortality and heart failure hospitalization rates observed.
  • Framework showed better prognostic discrimination than existing guidelines.
  • Caution advised regarding the use of thresholds for intervention eligibility.

Guideline-Based Recommendations

Diagnosis

  • Utilize standardized transthoracic echocardiography for assessment.

Management

  • Consider the proposed echocardiographic thresholds for risk stratification.

Monitoring & Follow-up

  • Follow patients for mortality and heart failure hospitalization outcomes.

Risks

  • Residual confounding may affect observational study conclusions.

Patient & Prescribing Data

Patients with transthyretin amyloid cardiomyopathy.

Thresholds developed for prognostic assessment, not for intervention eligibility.

Clinical Best Practices

  • Implement standardized core laboratory acquisition and measurement for echocardiographic assessments.
  • Use the proposed thresholds for improved prognostic evaluation.

Related Resources & Content

Original Source(s)

Related Content